Shares of CBT fell by 0.96% or $-0.36/share to $37.07. NYSE is trading at a price to book ratio of 1.3. The PEG is 0.69 suggesting that the shares are trading at an excellent value relative to firm's growth rate. The price to sales ratio came in at 0.71. Hence, the firm is extremely cheap relative to its top line sales figures. On average, 352403 shares of CBT exchange hands on a given day and today's volume is recorded at 93101. These financial metrics combined make this company seem undervalued. Lookout for any takeover chatter or takeover news regarding this stock as one of the bigger players may have an eye on this one.
Manufactures several industrial materials including specialty chemicals.
